FOXO4-DRI – 10mg
Research-Grade Senolytic Peptide
Tagline: Cellular Senescence & Longevity Research
Product Description
FOXO4-DRI is a synthetic D-retro inverso peptide derived from the FOXO4 protein sequence. It is a specialized research tool used to study senescent cell apoptosis, cellular aging, and tissue regeneration mechanisms.
By selectively disrupting the interaction between FOXO4 and p53 in senescent cells, FOXO4-DRI triggers targeted apoptosis of senescent cells while sparing healthy cells — making it a central compound in senolytic and longevity research models.
For Laboratory and Scientific Research Use Only. Not for Human Consumption.
Why Researchers Choose FOXO4-DRI
-
Senolytic Selectivity: Targets senescent cells via FOXO4–p53 pathway disruption
-
Longevity & Aging Research: Used to explore tissue rejuvenation and cellular clearance
-
Strong Preclinical Profile: Demonstrated restoration of tissue function in animal studies
-
Novel Mechanism: D-Retro-Inverso design increases stability and bioavailability
-
High Purity: ≥98% purity verified by HPLC/MS
Important Note
For laboratory and scientific research only. Not for human consumption, diagnostic, or therapeutic use.
